Search company, investor...
Theranos company logo


Founded Year



Dead | Dead

Total Raised


About Theranos

Theranos is a biomedical device company working on the field of Theranostics, the integration of technology with medical therapies to deliver the RIGHT drug, in the RIGHT dose, to the RIGHT patient at the RIGHT time. Theranos aims to provide clinical decision-support systems that enable pharmaceutical companies to develop safer, more efficacious drugs for individualized patient treatment.

Headquarters Location

1701 Page Mill Road

Palo Alto, California, 94304,

United States


Missing: Theranos's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Theranos's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Theranos

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Theranos in 2 CB Insights research briefs, most recently on Oct 17, 2022.

Expert Collections containing Theranos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Theranos is included in 3 Expert Collections, including Medical Devices.


Medical Devices

11,680 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting


Health IT

7,901 items

Theranos Patents

Theranos has filed 318 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Analytical chemistry
  • Blood tests
patents chart

Application Date

Grant Date


Related Topics




Software testing, Programming paradigms, Computational fluid dynamics, Health informatics, Medical terminology


Application Date


Grant Date



Related Topics

Software testing, Programming paradigms, Computational fluid dynamics, Health informatics, Medical terminology



Latest Theranos News

Theranos Frequently Asked Questions (FAQ)

  • When was Theranos founded?

    Theranos was founded in 2004.

  • Where is Theranos's headquarters?

    Theranos's headquarters is located at 1701 Page Mill Road, Palo Alto.

  • What is Theranos's latest funding round?

    Theranos's latest funding round is Dead.

  • How much did Theranos raise?

    Theranos raised a total of $500M.

  • Who are the investors of Theranos?

    Investors of Theranos include Fortress Investment Group, Rupert Murdoch, Riley Bechtel, Cox Enterprises, Threshold Ventures and 17 more.

  • Who are Theranos's competitors?

    Competitors of Theranos include Ischemia Care and 4 more.

Compare Theranos to Competitors


Aksys has developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient's home.

CSF Therapeutics

CSF Therapeutics is developing a cerebral blood flow device to prevent neurological debilitation and death, affecting more than 10 million individuals in the US alone, and includes indications such as stroke and Alzheimer's disease. Based on the research at The Cleveland Clinic, CSF Therapeutics' device is designed to increase cerebral blood flow indefinitely without affecting vascular or systemic function.

20/20 GeneSystems Logo
20/20 GeneSystems

20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a proprietary algorithm to combine the biomarker values to generate a unitary risk score.

Truvian Sciences Logo
Truvian Sciences

Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system produces lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers an alternative to off-site labs, providing immediate insights to inform healthcare decisions.


Nanotope is a regenerative medicine company that leverages a core set of technologies to address multiple therapeutic markets. Nanotope is developing a suite of products, each customized to regenerate specific tissues; including neuronal, vascular, bone, myocardial, and cartilage. The products are injectable compounds that work with surviving cells in and around the point of damage to initiate and support tissue regeneration and growth. Once regeneration is complete, the compounds are safely broken down and removed by the body. Nanotope's lead products target neuron regeneration for prevention or reversal of paralysis associated with spinal cord injury and angiogenesis for wound healing and the treatment of peripheral artery disease.n

Pulse Metric

Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.